Zhou L - Search Results

1

FGFR3 Nuclear Translocation Contributes to Proliferative Potential and Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Zhou L, Lu J, Liang ZY, Zhou WX, Jiang BL, Wang YZ, Liu CX, Huang BW, You L, Guo JC. Zhou L, et al. Among authors: zhou wx. Pancreas. 2022 May 1;51(5):476-482. doi: 10.1097/MPA.0000000000002056. Epub 2022 Jul 19. Pancreas. 2022. PMID: 35858182

2

Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer.

Zhou L, Li J, Zhao YP, Guo JC, Cui QC, Zhou WX, Zhang TP, Wu WM, You L, Shu H. Zhou L, et al. Among authors: zhou wx. Hepatobiliary Pancreat Dis Int. 2014 Oct;13(5):523-8. doi: 10.1016/s1499-3872(14)60272-1. Hepatobiliary Pancreat Dis Int. 2014. PMID: 25308363

3

Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer.

Guo JC, Li J, Zhao YP, Zhou L, Cui QC, Zhou WX, Zhang TP, You L. Guo JC, et al. Among authors: zhou l, zhou wx. PLoS One. 2015 Mar 19;10(3):e0120332. doi: 10.1371/journal.pone.0120332. eCollection 2015. PLoS One. 2015. PMID: 25789763 Free PMC article.

4

Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.

Zhou L, Yao LT, Liang ZY, Zhou WX, You L, Shao QQ, Huang S, Guo JC, Zhao YP. Zhou L, et al. Among authors: zhou wx. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14640-8. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823787 Free PMC article.

5

Expression of key mTOR pathway components in pancreatic ductal adenocarcinoma: A multicenter study for clinicopathologic and prognostic significance.

Zhou L, Yuan D, Zhang ZG, Liang ZY, Zhou WX, Yang JY, Jiang SH, Lu J, Zhang TP, You L, Guo JC, Zhao YP. Zhou L, et al. Among authors: zhou wx. Cancer Lett. 2017 Jun 1;395:45-52. doi: 10.1016/j.canlet.2017.02.036. Epub 2017 Mar 7. Cancer Lett. 2017. PMID: 28279716

6

High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma.

Liu WJ, Zhou L, Liang ZY, Zhou WX, You L, Zhang TP, Zhao YP. Liu WJ, et al. Among authors: zhou l, zhou wx. Pathol Res Pract. 2018 Feb;214(2):228-232. doi: 10.1016/j.prp.2017.11.013. Epub 2017 Nov 20. Pathol Res Pract. 2018. PMID: 29254792

7

Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma.

Lu J, Zhou L, Yang G, Liang ZY, Zhou WX, You L, Yuan D, Li BQ, Guo JC, Zhao YP. Lu J, et al. Among authors: zhou l, zhou wx. Hum Pathol. 2019 Apr;86:143-154. doi: 10.1016/j.humpath.2018.11.026. Epub 2018 Dec 9. Hum Pathol. 2019. PMID: 30537492

8

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma.

Liu WJ, Zhou L, Liang ZY, Zhou WX, You L, Zhang TP, Zhao YP. Liu WJ, et al. Among authors: zhou l, zhou wx. Chin Med J (Engl). 2018 Dec 20;131(24):2947-2952. doi: 10.4103/0366-6999.247211. Chin Med J (Engl). 2018. PMID: 30539907 Free PMC article.

9

High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinoma.

Jin Y, Liang ZY, Zhou WX, Zhou L. Jin Y, et al. Among authors: zhou l, zhou wx. Pathology. 2020 Apr;52(3):359-365. doi: 10.1016/j.pathol.2020.01.436. Epub 2020 Feb 28. Pathology. 2020. PMID: 32122646

10

Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study.

Guo JC, Zhang P, Zhou L, You L, Liu QF, Zhang ZG, Sun B, Liang ZY, Lu J, Yuan D, Tan AD, Sun J, Liao Q, Dai MH, Xiao GG, Li S, Zhang TP. Guo JC, et al. Among authors: zhou l. EBioMedicine. 2020 May;55:102767. doi: 10.1016/j.ebiom.2020.102767. Epub 2020 Apr 28. EBioMedicine. 2020. PMID: 32361251 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,597 results

Search Page

Filters